Skip to main content

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Miss. Supreme Court Temporarily Halts An Upcoming Talc Trial

Introduction

The Missouri Supreme Court passed an order on Monday, January 14, which temporarily paused an upcoming talcum powder trial involving claims filed by 13 women or their spouses, who alleged that Johnson & Johnson's asbestos-contaminated talc caused their ovarian cancer.

The order sustained a petition for a permanent writ of prohibition filed by J&J to stop the trial, which was slated to begin in St. Louis on Tuesday, January 15, and the jury selection for the same was about to begin this week. This was the second ovarian cancer case against J&J comprising of multiple plaintiffs. An earlier multi-plaintiff talc case concluded with a jury award of $4.7 billion granted to 22 women suffering from ovarian cancer. Attorney Beth Bauer wrote in the petition that consolidating too many plaintiffs into a single trial might confuse and mislead the jury in reaching towards an appropriate decision resulting in massive verdict amounts.

More than 1,000 lawsuits are pending against the talc manufacturer, which are centralized for pretrial proceedings in the District of New Jersey, presided over by Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. as a part of multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!